Skip to content
When it comes to long COVID, health care providers and the biotech industry must be aware of what is already known, but we still […]
BIO’s long COVID webinar furthers search for biotech solutions Read More »
In healthcare, business development (BD) is one of our most powerful tools to accelerate scientific innovation. In an industry where companies often race for
3 key insights to fostering successful collaboration in women’s health Read More »
For 17 years, BlackDoctor.org (BDO) has been the go-to place for education on public health in the Black community. As CEO Reggie Ware explains,
BDO understands communication is key for Black health Read More »
Pharmacy benefit managers, or PBMs, could be required to be more transparent about their business practices if Congress passes S. 127, the Pharmacy Benefit
Senate hearing considers Pharmacy Benefit Manager Transparency Act of 2023 Read More »
Biotechnology Innovation Organization (BIO) member Amyris has launched its new haircare line for curly and natural hair, paving the way for biotech innovators and
BIO member Amyris launches 4U by Tia™—clean beauty for textured hair Read More »
With the emergence of COVID-19 and the lack of timely response, the international community instantly realized that a foolproof plan for future pandemics is
Pharma recommends five essential priorities for future pandemic preparedness Read More »
Vulnerability to the impacts of climate change has been studied extensively in recent years but two new studies highlight specific impacts of changing weather
Human health seriously impacted by changing weather and air pollution Read More »
2023 is shaping up to be the year of RSV—in a good way. RSV (a.k.a. respiratory syncytial virus) has long been a challenge for
Pediatrics might finally have a long-awaited RSV shot Read More »
To assure the broad adoption of cutting-edge preventative measures that can shield Americans in the future, vaccine policy has to be changed, according to
Why vaccine policy must keep up with the science Read More »
Health and Human Services (HHS) is set to assess three drug payment models for Medicare and Medicaid in response to President Biden’s proposal to
HHS releases new drug payment models—here’s what you need to know Read More »
